NASDAQ:BBH VanEck Biotech ETF (BBH) Price, Holdings, & News → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free BBH Stock Alerts $155.13 -2.20 (-1.40%) (As of 01:50 PM ET) Add Compare Share Share Today's Range$153.47▼$156.7750-Day Range$151.99▼$167.0152-Week Range$142.51▼$171.04Volume52,031 shsAverage Volume9,097 shsMarket Capitalization$418.85 millionAssets Under Management$424.68 millionDividend Yield0.46%Net Expense Ratio0.35% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media Get VanEck Biotech ETF alerts: Email Address About VanEck Biotech ETF (NASDAQ:BBH)The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.Read More BBH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BBH ETF News HeadlinesMarch 29, 2024 | benzinga.comFuture-Proof Your Portfolio: Learn From ETF Expert Jan Van Eck In NYCMarch 22, 2024 | seekingalpha.comGNOM: Genomics Still Waiting For Its 'ChatGPT' MomentApril 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.January 30, 2024 | msn.comVanEck CEO Says Cryptos Deserve A Place In Everyone's PortfolioDecember 19, 2023 | msn.comVanEck Vectors Biotech ETF declares annual distribution of $0.7127December 9, 2023 | seekingalpha.comBBH: A Solid Way To Play A Comeback In BiotechOctober 24, 2023 | investing.comBBH ETF Stock Price HistorySeptember 13, 2023 | msn.comBBH: Our Favorite Biotech ETF Can Keep OutperformingApril 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.August 7, 2023 | morningstar.comVanEck ETFsSee More Headlines Receive BBH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerVan Eck Fund NameVanEck Biotech ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:BBH Inception Date12/20/2011 Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkMarket Vectors US Listed Biotech 25 Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionGlobal Number of Holdings26 Fund Statistics Assets Under Management$424.68 million Average Daily Volume$8,770.00 Discount/Premium-0.16% Administrator, Advisor and Custodian AdministratorVan Eck Associates Corporation AdvisorVan Eck Associates Corporation CustodianState Street Bank and Trust Company DistributorVan Eck Securities Corporation Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume1 Put Options1 Call Options1 Short Interest7,800 shs Miscellaneous Outstanding Shares2,700,000Beta0.74 Creation Unit50,000 Creation Fee$500.00 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. VanEck Biotech ETF ExpensesTypeBBHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.35%0.56%0.54%0.48%0.51%Other Expenses0.00%0.40%0.54%0.34%0.58%Total Expense0.35%0.72%0.70%0.58%0.70%Fee Waiver0.00%-0.53%-0.55%-0.22%-0.57%Net Expense0.35%0.60%0.60%0.54%0.58% VanEck Biotech ETF (BBH) Holdings & ExposureTop 10 BBH HoldingsAmgen(NASDAQ:AMGN)Holding Weight: 14.95%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 9.61%Gilead Sciences(NASDAQ:GILD)Holding Weight: 8.01%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 7.88%Moderna(NASDAQ:MRNA)Holding Weight: 5.66%IQVIA(NYSE:IQV)Holding Weight: 4.82%argenx(NASDAQ:ARGX)Holding Weight: 4.47%Biogen(NASDAQ:BIIB)Holding Weight: 4.27%ICON Public(NASDAQ:ICLR)Holding Weight: 4.20%Illumina(NASDAQ:ILMN)Holding Weight: 4.18%BBH Sector ExposureBBH Industry ExposureFull Holdings Details Similar ETFsVanEck Pharmaceutical ETFNASDAQ:PPHInvesco S&P SmallCap Health Care ETFNASDAQ:PSCHInvesco Dorsey Wright Healthcare Momentum ETFNASDAQ:PTHProShares Ultra Nasdaq BiotechnologyNASDAQ:BIBPrincipal Healthcare Innovators ETFNASDAQ:BTECInstitutional OwnershipAltfest L J & Co. Inc.Bought 319 shares on 4/22/2024Ownership: 0.292%Aspiriant LLCSold 2,955 shares on 4/15/2024Ownership: 0.163%Goldman Sachs Group Inc.Sold 1,072 shares on 3/1/2024Ownership: 4.075%CIBC Private Wealth Group LLCBought 3,458 shares on 2/13/2024Ownership: 0.123%Tower Research Capital LLC TRC Sold 1,625 shares on 2/13/2024Ownership: 0.009%View All Institutional Transactions BBH ETF - Frequently Asked Questions How have BBH shares performed in 2024? VanEck Biotech ETF's stock was trading at $165.31 at the start of the year. Since then, BBH stock has decreased by 6.7% and is now trading at $154.16. View the best growth stocks for 2024 here. Are investors shorting VanEck Biotech ETF? VanEck Biotech ETF saw a decline in short interest in April. As of April 15th, there was short interest totaling 2,500 shares, a decline of 67.9% from the March 31st total of 7,800 shares. Based on an average daily trading volume, of 7,200 shares, the short-interest ratio is currently 0.3 days. View VanEck Biotech ETF's Short Interest. How often does VanEck Biotech ETF pay dividends? What is the dividend yield for VanEck Biotech ETF? VanEck Biotech ETF announced an annual dividend on Friday, December 15th. Stockholders of record on Tuesday, December 19th will be given a dividend of $0.7127 per share on Friday, December 22nd. The ex-dividend date is Monday, December 18th. Read our dividend analysis for BBH. What does BBH invest in? VanEck Biotech ETF is a equity fund issued by Van Eck. BBH focuses on health care investments and follows the Market Vectors US Listed Biotech 25 Index. The fund's investments total to approximately $424.68 million assets under management. What stocks does VanEck Biotech ETF hold? BBH invests in 26 holdings. Some of the stocks in their portfolio include Amgen (AMGN), Vertex Pharmaceuticals (VRTX), Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), Moderna (MRNA), IQVIA (IQV), argenx (ARGX), Biogen (BIIB), ICON Public (ICLR) and Illumina (ILMN). What is the management fee for VanEck Biotech ETF? VanEck Biotech ETF's management fee is 0.35% and has no other recorded expenses or fee waivers. The net expense ratio for BBH is 0.35%. What other stocks do shareholders of VanEck Biotech ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Biotech ETF investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Intel (INTC), Micron Technology (MU), Cidara Therapeutics (CDTX), Quest Diagnostics (DGX), Novavax (NVAX). Who are VanEck Biotech ETF's major shareholders? VanEck Biotech ETF's stock is owned by a number of retail and institutional investors. Top institutional investors include Altfest L J & Co. Inc. (0.29%) and Aspiriant LLC (0.16%). How do I buy shares of VanEck Biotech ETF? Shares of BBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BBH) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchI’m afraid WWIII is a very real possibility Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
